GlassScriptPhysician profile
April B Turner
NPI 1528259413
$8,905.04
in general payments reported to CMS, 2019-2025
23 companies · $249 in 2025
The $249 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,357 · 2020: $361 · 2021: $112 · 2022: $1,260 · 2023: $1,906 · 2024: $1,661 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,535 · Travel and Lodging: $1,326 · Food and Beverage: $955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,535.31 |
| Travel and Lodging | $1,325.82 |
| Food and Beverage | $954.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,576.44 | 2019-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $1,307.62 | 2023-2025 | Gore Synecor Biomaterial |
| Ethicon US, LLC | $195.75 | 2019-2024 | Surgicel Nu-Knit, Vistaseal, Ethicon |
| Boston Scientific Corporation | $159.78 | 2019-2023 | Eluvia |
| Medical Device Business Services, INC. | $108.67 | 2023 | Vistaseal |
| Davol INC. | $103.21 | 2019-2023 | Phasix Mesh |
| Tela Bio, INC. | $94.92 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Alexion Pharmaceuticals, INC. | $43.55 | 2022 | |
| Medtronic, INC. | $41.34 | 2022 | |
| Acera Surgical, INC. | $39.29 | 2022-2023 | Restrata Wound Matrix |
| Innocoll Pharmaceuticals Limited | $37.35 | 2021-2022 | |
| Glaxosmithkline, LLC. | $28.27 | 2021 | |
| Kerecis Limited | $19.66 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Solventum Corporation | $18.78 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| La Jolla Pharmaceutical Company | $17.80 | 2024 | Xerava |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Z-Medica, LLC | $15.48 | 2019 | |
| Olympus America INC. | $15.11 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.93 | 2024 | Andexxa |
| Allergan, INC. | $14.77 | 2020 | |
| Misonix INC | $14.57 | 2020 | |
| Teleflex LLC | $12.99 | 2022 | |
| Merck Sharp & Dohme LLC | $12.52 | 2019 | |
| Acell, INC. | $12.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.